Tanshinone I induces apoptosis and protective autophagy in human glioblastoma cells via a reactive oxygen species‑dependent pathway

Glioma is the most common primary malignancy of the central nervous system and is associated with high mortality rates. Despite the available treatment options including surgery, radiotherapy and chemotherapy, the median patient survival rate is low. Therefore, the development of novel Anticancer agents for the treatment of glioma is urgently required. Tanshinone I (TS I) is a tanshinone compound that is isolated from Danshen. Accumulating evidence indicates that TS I exhibits antiproliferative activity in a variety of Cancer types. However, the role of TS I and its mechanism of action in human glioma remain to be elucidated. In the present study, the Anticancer potential of TS I against human glioma U87 MG cells was investigated. The results indicated that TS I exerted a potential cytotoxic effect on human glioma U87 MG cells. TS I was found to induce cell proliferation, inhibition, cell cycle arrest, Apoptosis and Autophagy in U87 MG cells. Mechanistic experiments indicated that TS I activated endoplasmic reticulum (ER) stress and inhibited Akt signaling and Apoptosis in human glioma U87 MG cells. Furthermore, the present study demonstrated that TS I induced protective Autophagy in U87 MG cells. Additionally, ER stress and Akt signal‑mediated Apoptosis and protective Autophagy were found to be induced by TS I via intracellular Reactive Oxygen Species accumulation. The results of the present study demonstrated that TS I may be a potential Anticancer drug candidate that may be of value in the treatment of human glioma.